For US Healthcare Professionals
I am a:
Sign-up Portal
Explore coverage options in your area
Collected in 09/25 and subject to change. This information does not provide advice or guarantee coverage or payment. Legal requirements and plan information can be updated frequently. We strongly recommend contacting the plan for more information about current coverage, restrictions, or prerequisites that may apply.
Source: Managed Markets Insight & Technology, LLC™, a trademark of MMIT, as of September 2025. Data On File, as of 09/2025. Collected as of 09/25 and may change.
*“Nearly” means absolute difference less than +/-2% of the actual number. Within 2% of the access being stated.
†These percentages may not represent 100% of formulary lives due to data limitations.
‡“Superior” means difference is greater than 10%. The information provided does not imply comparable safety or efficacy between products and only represents access information. Indicated trademarks are the registered trademarks of their respective owners. Please refer to each product’s Prescribing Information for indication(s), recommended dosing, and administration.
§“Outstanding” means >90% number of covered lives.
||“Preferred” means TREMFYA® can be accessed first-line (ie, step therapy is not required) and its formulary status is better than or equivalent to other products in the class.
IN ADULTS WITH MODERATE TO SEVERE PLAQUE PsO
